13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001569241
Total reported value
$800.9M
$800.9M
40 檔
27.8%
As reported in its official Q2 2024 Form 13F filing, Newtyn Management, LLC's tracked investment portfolio stood at $800.9M with 40 total positions.
During Q2 2024, Newtyn Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PPLI | People Inc | Stock-Comm Services | 12.53% | — | +0.14% | |
| 2 | PAR | Par Technology Corp/del | Stock-Other | 8.62% | +1.37% | -21.81% | |
| 3 | QDEL | Quidelortho CORP | Stock-Other | 6.95% | +6.49% | — | |
| 4 | SOLV | Solventum CORP | Stock-Healthcare | 6.95% | — | — | |
| 5 | VTOL | Bristow Group Inc | Stock-Other | 6.80% | — | +0.53% | |
| 6 | AIV | Apartment Invt & Mgmt Co -a | Stock-Other | 5.87% | -0.79% | +25.65% | |
| 7 | CCOI | Cogent Communications Holdin | Stock-Other | 5.56% | -0.35% | +40.00% | |
| 8 | BV | Brightview Holdings Inc | Stock-Other | 4.37% | +0.78% | — | |
| 9 | OFIX | Orthofix Medical Inc | Stock-Other | 4.15% | — | +31.16% | |
| 10 | SPB | Spectrum Brands Holdings Inc | Stock-Other | 4.03% | +0.52% | — | |
| 11 | CIO | City Office Reit Inc | Stock-Other | 3.59% | — | — | |
| 12 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 3.38% | -1.11% | +29.25% | |
| 13 | CLFD | Clearfield Inc | Stock-Other | 3.02% | — | +4.39% | |
| 14 | CNNE | Cannae Holdings Inc | Stock-Other | 2.66% | +1.73% | -63.01% | |
| 15 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 2.33% | — | +36.61% | |
| 16 | SHC | Sotera Health Co | Stock-Other | 2.12% | — | — | |
| 17 | FSP | Franklin Street Properties C | Stock-Other | 2.05% | -0.05% | — | |
| 18 | MBI | Mbia Inc | Stock-Other | 1.93% | — | — | |
| 19 | BVFL | BV Financial Inc | Stock-Other | 1.85% | — | -5.16% | |
| 20 | TSVT* | 2seventy Bio Inc | Stock-Other | 1.80% | — | — | |
| 21 | NODK | Ni Holdings Inc | Stock-Other | 1.74% | +0.39% | +0.06% | |
| 22 | STHO | Star Holdings | Stock-Other | 1.06% | — | -1.62% | |
| 23 | FET 9 08-04-25Bond | Forum Energy Technologie | Bond | 1.03% | — | — | |
| 24 | PCG | P G & E CORP | Stock-Utilities | 0.88% | — | — | |
| 25 | FBTC | Fidelity Wise Origin Bitcoin | ETF-Crypto | 0.86% | — | — | |
| 26 | HP5A | Equity Commonwealth | Stock-Other | 0.60% | — | — | |
| 27 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.44% | -0.07% | -5.00% | |
| 28 | MITK | Mitek Systems Inc | Stock-Other | 0.42% | — | -82.76% | |
| 29 | KOD | Kodiak Sciences Inc | Stock-Other | 0.41% | — | -7.00% | |
| 30 | ETNBGBP | 89bio Inc | Stock-Other | 0.36% | — | -4.00% | |
| 31 | ✓ | Mural Oncology Pub LTD Co | Stock-Other | 0.34% | — | +14.00% | |
| 32 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.30% | — | — | |
| 33 | OLMA | Olema Pharmaceuticals Inc | Stock-Other | 0.28% | — | -6.67% | |
| 34 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 0.24% | — | -5.00% | |
| 35 | BOLT1EUR | Bolt Biotherapeutics Inc | Stock-Other | 0.19% | — | -19.81% | |
| 36 | GRAL | Grail Inc | Stock-Healthcare | 0.10% | +0.45% | — | |
| 37 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.08% | — | -24.00% | |
| 38 | FET | Forum Energy Technologies In | Stock-Other | 0.05% | — | -92.28% | |
| 39 | ✓ | Aligos Therapeutics Inc | Stock-Other | 0.05% | — | -40.06% | |
| 40 | LFLYW | Merida Merger CORP I -cw26 | Stock-Other | — | — | — |
According to official SEC Form 13F filings, Newtyn Management, LLC reported a total U.S. public equity portfolio value of $800.9M across 40 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including PPLI, PAR, QDEL) accounted for 27.8% of total reported equity market value during Q2 2024.
During Q2 2024, Newtyn Management, LLC's top holdings by market value included PPLI (12.5%)、PAR (8.6%)、QDEL (7.0%). The largest single position, PPLI, represented 12.5% of total portfolio value.
In Q2 2024, Newtyn Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.